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Signaling complexity is the nightmare
of every systems biologist. Some
hope that the pathway of interest can
be considered in isolation, or else pur-
sue their slightly more accessible
bacterial cousins. Others dive into the
complexity of mammalian signaling
pathways, at least within the safety of
mathematical modeling. This is what
Rowland et al. (1) did with a focus on
crosstalk between pathways, pub-
lished in this issue of the Biophysical
Journal.
The problem researchers face is that
the human genome encodes hundreds
of different phosphatases and kinases.
To make things worse, kinases can
have many different targets. For in-
stance, Akt and receptor tyrosine
kinases of the EGF/ErbB family can
selectively interact with over a dozen
substrates each. And while there are
fewer phosphatases than kinases, they
are also more promiscuous or use
adaptor proteins to act upon many dif-
ferent substrates. As some of these
pathways lead to strong amplification
of incoming signals, they are popular
targets of pharmaceutical inhibitors.
However, due to the crosstalk, predict-
ing an inhibitor’ specific effects is ren-
dered difficult.
The basic foundation of the work by
Rowland et al. sits on the futile cycle of
a kinase and a phosphatase acting upon
a substrate. Goldbeter and Koshland
(2) established in the 1980s that when
these antagonizing enzymes work athttp://dx.doi.org/10.1016/j.bpj.2012.10.007
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independent of the substrate concentra-
tion, the result is ultra-high sensitivity.
If the forward reaction rate, e.g., due to
a stimulus, is minimally larger than
the reverse reaction rate, all substrate
becomes phosphorylated in an all-
or-none fashion. The opposite is true
when the reverse reaction slightly
dominates. In reality, however, these
cycles occur within larger pathways,
with the mitogen-activated protein
kinase cascade for cell growth a
classical example. These and similar
pathways can have multiple useful
functions for the cell (3), including
heightened sensitivity to stimuli via
amplification along the cascade (4).
Alternatively, cascades can produce
oscillations and reduce noise with neg-
ative feedback from the end to the
beginning of the cascade. Or cascades
can make bistable switches and ex-
hibit hysteresis with positive feedback
from the beginning to the end of the
cascade (5). Substrates can also have
many phosphorylation sites, e.g., as
occurs for the enzymes involved in
pheromone sensing in budding yeast
(6) or the p53 transcription factor in
humans (7).
However, what about the pressing
issue of understanding crosstalk be-
tween pathways under physiological
conditions? Rowland et al. systemati-
cally started from a simple pathway
with two substrates, where a single
kinase and a single phosphatase are
shared. Each substrate acts as a com-
petitive inhibitor for the modification
of the other substrate, as both sub-
strates compete for the same enzymes.
As a result, an ultrasensitive response
of one substrate is transferred to the
other substrate, even if it does not sat-
urate the enzymes itself. With many
substrates available, the entire system
can show ultrasensitivity even when
none of the substrates saturate the
kinase and phosphatase individually.
What if only the kinase or phospha-
tase is shared? Consider two substrates.
For two individual phosphatases and
a shared kinase, the saturating substratecan act as a type of gatekeeper and im-
pose a response threshold on the other
substrate (see also Harrington et al.
(8)). In contrast, for two individual
kinases and a shared phosphatase, the
saturating substrate essentially en-
slaves the other substrate in responding
ultrasensitively as well. From here, the
authors moved on to cascades in which
the phosphorylated substrates act as the
kinase of the next substrate.
If the phosphatase is shared for all
steps of the cascade, the outcome is
an even greater sensitivity. This arises
because the upstream kinase not only
produces more phosphorylated sub-
strate at each step but the phosphory-
lated substrates also, collectively,
inhibit the shared phosphatase. Row-
land et al. introduce the term ‘‘phos-
phatase tunneling’’ for this effect,
another example of the new vocabulary
required by the subtle mechanisms
they have uncovered. Such intuitive
vocabulary has a long tradition is
physics-based modeling. Famously,
‘‘quasi-horse’’ was humorously intro-
duced to describe the many-body
effect of a horse with its surrounding
dust particles and flies (9).
Due to the experimental complexity,
no direct comparison with data is yet
available, although some progress has
been made using inverse modeling. In
this context, the study by Sachs et al.
(10) using Bayesian inference and
multicolor flow cytometry comes to
mind. However, even in absence of ac-
tual data, the article teaches awe of the
complexity of real signaling cascades,
as well as mindfulness when develop-
ing pharmaceutical inhibitors for drug
applications. As the authors show, in-
hibitors can have multiple counterintu-
itive effects. For instance, inhibiting
the phosphorylation reaction between
a kinase and one particular substrate
can lead to the increased responsive-
ness and phosphorylation of another
substrate if the kinase is shared. Hence,
to avoid turning signaling cascades
2242 Endresinto wild hornets’ nests or tricky spider
webs, the full network architecture
needs to be deciphered when trying to
make rational predictions.
We thank Erin Ingrassia and Heather Harrington
for critical reading of the manuscript.REFERENCES
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